The Melanoma Nursing Initiative – Home › Forums › Immunotherapy › Expectations for therapy › Adjuvant Immunotherapy in stage IIIA patients › Reply To: Adjuvant Immunotherapy in stage IIIA patients
March 5, 2018 at 4:13 am #4726
Expert NurseKrista Rubin
We have been taking this on a case-by-case basis. Though IIIA patients have a favorable prognosis, there are some patients that have a more worrisome feature than the “average IIIA”. For those patients, a detailed risk/benefit discussion is essential, and the patient would be made aware of the data (not including IIIA).